<DOC>
	<DOCNO>NCT01392846</DOCNO>
	<brief_summary>This prospective , observational , cohort study evaluate relative efficacy safety Resolute Integrity stent compare ( drug elute stent ) DES .</brief_summary>
	<brief_title>The IRIS-Resolute Integrity ( IRIS-Integrity )</brief_title>
	<detailed_description>Consecutive Percutaneous Coronary Intervention patient receive Resolute Integrity stent compare concurrent Drug Eluting Stents .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients significant coronary artery disease receive Resolute Integrity stent . The patient guardian agrees study protocol schedule clinical followup , provide informed , write consent , approve appropriate Institutional Review Board/Ethics Committee respective clinical site . Patients mixture DESs Terminal illness life expectancy &lt; 1 year Patients present cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Coronary artery disease require drug elute stent</keyword>
</DOC>